Menu

Pharma News

Business Aquisition V13F07

Epirus expands biosimilars pipeline with Bioceros acquisition

Home/Pharma News | Posted 02/10/2015

US-based Epirus Biopharmaceuticals (Epirus) announced on 9 September 2015 that it has acquired Netherlands-based biopharmaceutical company Bioceros Holding (Bioceros).

Generics Blue Cap V13C15

UCB sells generics unit to Lannett

Home/Pharma News | Posted 11/09/2015

Belgium-based biopharmaceutical company UCB announced on 2 September 2015 that it would sell its US specialty generics business, Kremers Urban, to US generics company Lannett for US$1.23 billion in cash plus contingent payments.

Shaking hands V13D29

US FTC clears Pfizer’s purchase of Hospira

Home/Pharma News | Posted 04/09/2015

Pharma giant Pfizer announced on 24 August 2015 that the US Federal Trade Commission (FTC) terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to Pfizer’s pending acquisition of US-based injectable generics specialist and biosimilars maker Hospira.

Australia flag V13C29

ANI Pharma and IDT Australia collaborate on US generics

Home/Pharma News | Posted 28/08/2015

US-based brand-name and generic drugmaker ANI Pharmaceuticals (ANI) announced on 12 August 2015 that it had entered into a collaboration with generics company IDT Australia (IDT) to commercialize up to 18 previously marketed US generics.

picture 66

Mergers between Watson/Actavis and ANI Pharma/BioSante

Home/Pharma News | Posted 19/10/2012

Mergers are once again on the agenda as companies strive to meet the constant demands of governments to cut costs and yet still make a profit.

Shaking hands V13D29

AstraZeneca and Fujifilm Kyowa Kirin Biologics to collaborate on bevacizumab biosimilar

Home/Pharma News | Posted 21/08/2015

Japanese biosimilars maker Fujifilm Kyowa Kirin Biologics announced on 24 July 2015 that it had entered into an agreement with pharma giant AstraZeneca to establish a joint venture for the development and commercialization of its candidate biosimilar, FKB238.

picture 84

Hikma to acquire Boehringer Ingelheim’s US generics business

Home/Pharma News | Posted 21/08/2015

Jordan-based drugmaker Hikma Pharmaceuticals (Hikma) announced on 28 July 2015 that it had made a deal with Germany’s Boehringer Ingelheim to acquire the latter’s US generics business: Roxane Laboratories and Boehringer Ingelheim Roxane (Roxane).

Shaking hands V13D29

Lupin to expand US generics business with Gavis acquisition

Home/Pharma News | Posted 07/08/2015

Indian generics manufacturer Lupin Pharmaceuticals (Lupin) announced on 23 July 2015 that it had entered into a definitive agreement to acquire US generics makers Gavis Pharmaceuticals and Novel Laboratories (Gavis).

Shaking hands V13D29

Acquisitions for Endo and Strides

Home/Pharma News | Posted 26/06/2015

Endo Pharmaceuticals (Endo) and Strides Arcolab (Strides) are both looking at acquisitions as a way to expand their generics businesses.

Shaking hands V13D29

Amneal to acquire Australian generics business from Actavis

Home/Pharma News | Posted 15/05/2015

Privately held US generics maker Amneal Pharmaceuticals (Amneal) announced on 31 March 2015 that it had made a deal with the Australian subsidiary of Actavis to acquire the Australian generics business of Actavis for an undisclosed amount.